Form 8-K AveXis, Inc. For: Mar 27 – StreetInsider.com
EconoTimes |
Form 8-K AveXis, Inc. For: Mar 27
StreetInsider.com Chicago, Ill. (March 27, 2018) — AveXis, Inc. (NASDAQ: AVXS), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, today announced that Japan's Ministry of … QS Investors LLC Invests $156000 in AveXis Inc (AVXS) |
